Physical Activity, Sleep, and Sedentary Behavior Effects on Heart Risk in Adults with Rheumatoid Arthritis
Led by São Paulo State University · Updated on 2026-08-20
150
Participants Needed
1
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating how daily movement behaviors, including physical activity, sedentary time, and sleep, relate to the risk of atherosclerosis in adults with rheumatoid arthritis. This observational study aims to understand whether these behaviors alone or combined are linked to cardiovascular risk indicators and how changes over 12 months affect vascular health. Rheumatoid arthritis increases cardiovascular risk beyond traditional factors, making this research important for improving heart health management in this group.
Participants will wear accelerometers for 7 continuous days to objectively measure movement behaviors and sleep. They will also complete health and lifestyle questionnaires. Cardiovascular health will be assessed through various tests including pulse wave velocity, blood pressure measurements, and imaging for atherosclerotic indicators. Follow-up assessments will occur 12 months after baseline to observe changes over time.
Throughout the study, participants will undergo physical fitness tests, body composition measurements, blood tests for lipid and inflammatory markers, and comprehensive cardiovascular evaluations. Researchers will analyze data to explore relationships between movement behaviors and cardiovascular risk, using advanced statistical methods. The total participation spans baseline and a 12-month follow-up, aiming to provide insights for future lifestyle recommendations in rheumatoid arthritis care.
CONDITIONS
Brief Title
Twenty-four Hour Movement Behaviors and Atherosclerotic Risk
Research Team
W
William R Tebar, PhD
W
William R Tebar, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Independence in daily living activities defined as a Katz Index score of 5 or 6 points
You will not qualify if you...
Acute infectious disease at the time of assessment
Pregnancy or breastfeeding
Cognitive impairment as per Mini-Mental State Examination cutoffs
History of cardiovascular disease including coronary artery disease, cerebrovascular disease, peripheral arterial disease, rheumatic heart disease, congenital heart disease, deep vein thrombosis, or pulmonary embolism
Use of uncontrolled vasoactive medication
Inability to comply with accelerometer wear requirements
Inability to complete study questionnaires or physical assessments
Invalid accelerometer data according to wear-time criteria
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Data Collection
Duration - 1 week
Participants wear accelerometers for 7 days to track movement behaviors and sleep. They complete questionnaires and undergo cardiovascular, physical fitness, body composition, and blood assessments at baseline.
1 baseline visit and 7 days of device wear
Follow-up Assessments
Duration - 1 day
Participants return 12 months later for repeat cardiovascular, physical fitness, body composition, blood tests, and questionnaires to observe changes over time.
1 follow-up visit
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Exploratory Study of Single Infusion YTS109 Cell Therapy in Adults With Relapsed or Refractory Autoimmune Diseases
Evaluating the Safety and Effectiveness of Oral AP1189 with Methotrexate in Adults with Early Rheumatoid Arthritis Not Previously Treated with DMARDs
Phase 1 Study of KT501 Injection to Assess Safety and Effects in Adults With Rheumatoid Arthritis
Phase 1 Study of KT502 Injected Under the Skin in Adults
With Rheumatoid Arthritis to Evaluate Safety and Dosage
Long-Term Follow-Up Study to Assess Safety of Gene-Modified Regulatory T Cell Therapy in Adults
Long-Term Follow-Up Study for Adults Previously Treated with KYV-101 CAR T-Cell Therapy
Phase 1 Study of ADI-001 Anti-CD20 CAR-T Cells for Adults with Treatment-Resistant Rheumatoid Arthritis
Phase I Study of QLS12010 Capsules to Assess Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effects in Healthy Adults and Adults with Moderate to Severe Atopic Dermatitis
Evaluating the Safety and Preliminary Effectiveness of Oral JAB-8263 for Active Rheumatoid Arthritis in a Phase IIa Study
Real-World Study of Subcutaneous Methotrexate Treatment in Chinese Adults with Rheumatoid Arthritis and Related Conditions
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Canadian 24-Hour Movement Guidelines for Adults aged 18-64 years and Adults aged 65 years or older: an integration of physical activity, sedentary behaviour, and sleep.
Robert Ross, Jean-Philippe Chaput, Lora M Giangregorio...
Combined Effects of Time Spent in Physical Activity, Sedentary Behaviors and Sleep on Obesity and Cardio-Metabolic Health Markers: A Novel Compositional Data Analysis Approach.
Sebastien F M Chastin, Javier Palarea-Albaladejo, Manon L Dontje...
Twenty-four hour physical activity, sedentary behaviour and sleep profiles in adults living with rheumatoid arthritis: a cross-sectional latent class analysis.